PATENT CLAIM ANALYSIS

Application Number: 16130242
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "661000"]

Abstract:
The present invention relates to methods of treating and/or preventing obesity comprising the administration of antioxidant inflammation modulators described herein, including for example bardoxolone methyl.

Claim (Index 140):
The method of  claim 135 , wherein at least a portion of the compound is present as an amorphous form having an X-ray diffraction pattern (CuK\u03b1) with a halo peak at approximately 13.5 \u00b02\u03b8, as shown in  FIG. 1C , and a T g  from about 120\u00b0 C. to about 135\u00b0 C.

Metadata:
- Claim Count in Document: 99.0
- Percentile: 97.0
- Lexical Diversity: 1.03846
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13085338', '13359381', '13055418', '12352473', '13645187']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6686002664040572
- 35 USC 102 Novelty (BERT): 0.5394378322218772
- Combined Prediction Score: 0.6556840229858393
- Mean Citation Score: 228.86555400000003
- Max Citation Score: 360.00668
- Similarity Product: 330.4526514704419

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test